These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21513881)

  • 21. Honokiol induces a necrotic cell death through the mitochondrial permeability transition pore.
    Li L; Han W; Gu Y; Qiu S; Lu Q; Jin J; Luo J; Hu X
    Cancer Res; 2007 May; 67(10):4894-903. PubMed ID: 17510419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platinum resistant cancer cells conserve sensitivity to BH3 domains and obatoclax induced mitochondrial apoptosis.
    Crawford N; Chacko AD; Savage KI; McCoy F; Redmond K; Longley DB; Fennell DA
    Apoptosis; 2011 Mar; 16(3):311-20. PubMed ID: 21107700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. To determine the cytotoxicity of chlorambucil and one of its nitro-derivatives, conjugated to prasterone and pregnenolone, towards eight human cancer cell-lines.
    Shervington LA; Smith N; Norman E; Ward T; Phillips R; Shervington A
    Eur J Med Chem; 2009 Jul; 44(7):2944-51. PubMed ID: 19121874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bifunctional peptide hybrids targeting the matrix of mitochondria.
    Klimpel A; Neundorf I
    J Control Release; 2018 Dec; 291():147-156. PubMed ID: 30367921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
    Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
    Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re-directing an alkylating agent to mitochondria alters drug target and cell death mechanism.
    Mourtada R; Fonseca SB; Wisnovsky SP; Pereira MP; Wang X; Hurren R; Parfitt J; Larsen L; Smith RA; Murphy MP; Schimmer AD; Kelley SO
    PLoS One; 2013; 8(4):e60253. PubMed ID: 23585833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein ruthenation and DNA alkylation: chlorambucil-functionalized RAPTA complexes and their anticancer activity.
    Nazarov AA; Meier SM; Zava O; Nosova YN; Milaeva ER; Hartinger CG; Dyson PJ
    Dalton Trans; 2015 Feb; 44(8):3614-23. PubMed ID: 25407500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chlorambucil-sensitive and -resistant lymphoid cells display different responses to the histone deacetylase inhibitor, sodium butyrate.
    Kwa FA; Cole-Sinclair M; Kapuscinski M
    Biochem Biophys Res Commun; 2010 Dec; 403(3-4):288-92. PubMed ID: 21075074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines.
    Manetta A; Gamboa G; Nasseri A; Podnos YD; Emma D; Dorion G; Rawlings L; Carpenter PM; Bustamante A; Patel J; Rideout D
    Gynecol Oncol; 1996 Feb; 60(2):203-12. PubMed ID: 8631539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.
    Pathania D; Millard M; Neamati N
    Adv Drug Deliv Rev; 2009 Nov; 61(14):1250-75. PubMed ID: 19716393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutation of p53 and consecutive selective drug resistance in B-CLL occurs as a consequence of prior DNA-damaging chemotherapy.
    Sturm I; Bosanquet AG; Hermann S; Güner D; Dörken B; Daniel PT
    Cell Death Differ; 2003 Apr; 10(4):477-84. PubMed ID: 12719725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).
    Pu Q; Bianchi P; Bezwoda WR
    Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting therapy with mitosomal daunorubicin plus amlodipine has the potential to circumvent intrinsic resistant breast cancer.
    Zhang Y; Li RJ; Ying X; Tian W; Yao HJ; Men Y; Yu Y; Zhang L; Ju RJ; Wang XX; Zhou J; Chen JX; Li N; Lu WL
    Mol Pharm; 2011 Feb; 8(1):162-75. PubMed ID: 21062083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity studies of novel amidine analogues of chlorambucil: correlation of cytotoxic activity with DNA-binding affinity and topoisomerase II inhibition.
    Bielawska A; Bielawski K; Wołczyński S; Anchim T
    Arch Pharm (Weinheim); 2003 Aug; 336(6-7):293-9. PubMed ID: 12953217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia.
    Pahler JC; Ruiz S; Niemer I; Calvert LR; Andreeff M; Keating M; Faderl S; McConkey DJ
    Clin Cancer Res; 2003 Oct; 9(12):4570-7. PubMed ID: 14555532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
    Wang W; Liu G; Zheng J
    Eur J Pharmacol; 2007 Jul; 568(1-3):61-7. PubMed ID: 17509556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted combinational therapy inducing mitochondrial dysfunction.
    Shin WS; Park SK; Verwilst P; Koo S; Lee JH; Chi SG; Kim JS
    Chem Commun (Camb); 2017 Jan; 53(7):1281-1284. PubMed ID: 28067351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hybrid of DNA-targeting Chlorambucil with Pt(IV) Species to Reverse Drug Resistance.
    Chen F; Xu G; Qin X; Jin X; Gou S
    J Pharmacol Exp Ther; 2017 Nov; 363(2):221-239. PubMed ID: 28916659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analysis of DNA alkylation by conjugates between pyrrole-imidazole hairpin polyamides and chlorambucil or seco-CBI.
    Minoshima M; Bando T; Shinohara K; Kashiwazaki G; Nishijima S; Sugiyama H
    Bioorg Med Chem; 2010 Feb; 18(3):1236-43. PubMed ID: 20074970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells.
    Walker A; Taylor ST; Hickman JA; Dive C
    Cancer Res; 1997 May; 57(10):1939-45. PubMed ID: 9157989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.